Thomas FrischmuthManaging Director at baseclick GmbHSpeaker
Profile
Since more than 30 years Thomas Frischmuth is actively working in the life science field as researcher (university as well as industry, more than 70 publications and several patents), advisor and consultant (companies and public organization) and in management position.
The research activities ranges from chemical synthesis (small scale and large scale), chemical analyses, molecular and cell biology, biotech synthesis (small and large scale), diagnostic, medical device (heart support systems), agriculture and drug to treatment development.
Thomas developed and evaluated 6 drugs and vaccines pre-clinically and brought 4 of them into clinical evaluation studies. One drug is marketed for cancer treatment.
In 2003, Thomas founded his own private venture fund company (Gradus Venture GmbH) and since then has co-founded and invested of today in 6 companies.
Agenda Sessions
Development of Targeted Oligonucleotide Therapy for Respiratory Diseases
, 08:30View Session